Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral N-acetylcysteine versus pregabalin for painful diabetic neuropathy
IRCT20180814040795N1Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of acetylcysteine and pregabalin in diabetic polyneuropathy (DPN) (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoints: Visual Analog Scale pain score, Serum lipid peroxidation and 6 more. Started Aug 2018; status: completed.
02
Drugs
acetylcysteinepregabalin
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on IRCT20180814040795N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180814040795N1.